Rapid drop in blood platelet count and increase in creatinine in non-small cell lung cancer (NSCLC) patients treated with osimertinib. This is an ASCO Meeting Abstract from the 2018 ASCO Annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback